December 2, 2016 - 21st Century Cures Bill Passes House

The 21st Century Cures Act passed the House of Representatives on November 30.  It authorizes $4.8 billion over a ten year period for targeted initiatives at the NIH and $500 million for the FDA.  The bill is expected to be voted on in the Senate the week of December 5.  The Office of Public Affairs has prepared an analysis of the bill's provisions.

November 10, 2016 - ASM and PASCV Comment on Transplant Virus Testing

The ASM and Pan American Society for Clinical Virology (PASCV)  comment on reclassification of tests for the measurement of virus DNA levels in transplant-associated infections.

Department of Defense - FY 2017

The ASM submitted funding recommendations to Congress for the U.S. Department of Agriculture for fiscal year 2017.

October 26, 2016 - ASM Joins PEW, IDSA and BD in Breakpoints Letter to Senate HELP Committee

ASM, PEW, IDSA and BD sent a letter to Senate HELP Committee Chairman Alexander and Ranking Member Murray asking them to consider language to streamline the process for updating breakpoints as they work to finalize the 21st Century Cures innovation legislation. 

Department of Energy - FY 2017

The ASM submitted funding recommendations to Congress for the Department of Energy for fiscal year 2017.

October 26, 2016 - ASM Joins PEW, IDSA and BD in Breakpoints Letter to Senate HELP Committee

ASM, PEW, IDSA and BD sent a letter to Senate HELP Committee Chairman Alexander and Ranking Member Murray asking them to consider language to streamline the process for updating breakpoints as they work to finalize the 21st Century Cures innovation legislation.

PSAB Funding Statements from 1997

The content of this page is restricted to ASM Members only.

Please login at the top-right or to become a member, join ASM.

October 17, 2016 - ASM, AMP and PASCV Express Concerns On New Molecular Test for Zika

The ASM, the Association for Molecular Pathology (AMP) and Pan American Society for Clinical Virology (PASCV) ask for data and clarification on the rRT-PCR assay for the testing of Zika, dengue and chikungunya viruses.

March 14, 2016 - ASM Comments on Select Agents and Toxins Regulations

The ASM sent comments to the Centers for Disease Control and Prevention (CDC) and the Animal and Plant Health Inspection Service (APHIS) regarding the biennial review of the List of Select Agents and Toxins and enhanced biosafety requirements. 

September 29, 2016 - Congress Passes Short-term Continuing Resolution and Funds Zika Response

The ASM Office of Public Affairs has summarized the details of the Continuing Resolution that includes funding to combat Zika.

ASM Funding Recommendations to Congress for Fiscal Year 2017

The ASM has submitted appropriation recommendations to Congress for federal agencies that support biomedical and public health research.

 

November 9, 2016 - ASM Recommendations to the Presidential Transition

The ASM sent policy recommendations to strengthen science, technology and public health in the United States.

U.S. Department of Agriculture - FY 2017

The ASM submitted funding recommendations to Congress for the U.S. Department of Agriculture for fiscal year 2017.

August 30, 2016 - ASM Asks for Clarification on CLIA Personnel Regulations

ASM requests clarification on an April CMS State Survey Agency Directors memorandum regarding personnel policies on individuals performing non-waived tests.

National Science Foundation - FY 2017

The ASM submitted funding recommendations to Congress for the National Science Foundation for fiscal year 2017.

August 29, 2016 - ASM Letter Concerning UN Meeting on Antimicrobial Resistance

ASM sent a letter Samantha Power, the US Ambassador to the United Nations regarding the September 21 meeting of the UN General Assembly on antimicrobial resistance

Food and Drug Administration - FY 2017

The ASM submitted funding recommendations to Congress for the Food and Drug Administration for fiscal year 2017.

ASM Actions on Zika


Zika Funding Update

Zika tnSeptember 29, 2016 - Congress Passes Short-term Continuing Resolution and Funds Zika Response
The ASM Office of Public Affairs has summarized the details of the Continuing Resolution that includes funding to combat Zika.

Funding Alert: Contact Congress for Emergency Funding for Zika
The ASM has been working since February to urge congressional passage of a $1.9 billion emergency supplemental funding bill to respond to the Zika virus. The House and Senate passed Zika funding bills, but a conference agreement failed in the Senate over political controversy, stalling congressional passage of a final Zika funding bill before Congress left for the summer recess.  Please click the link above to contact your congressional delegation to urge immediate passage of a bipartisan emergency supplemental bill for Zika.

ASM Acts to Counter Zika Virus Outbreak
A summary of all Zika related ASM activities.

ASM Letters and Statements

August 5, 2016 - ASM Urges Public Health Actions and Funding to Combat Zika Emergency

July 18, 2016 - ASM Urges Congressional Action on Emergency Zika Funding
The ASM sent Majority Leader McConnell and Minority Leader Reid, Speaker Ryan and Minority Leader Pelosi a letter urging action on funding to combat the threat of Zika.

May 18, 2016 - ASM Supports $1.9 Billion Emergency Funding to Combat Zika
The ASM sent a letter to Congress supporting the full $1.9 emergency funding request to combat Zika.

April 8, 2016 - ASM Letter on Zika and Emerging Infectious Disease Funding
The ASM sent a letter to Congress regarding emergency funding for the Zika outbreak.  The ASM supports providing new funding to fight public health emergencies.

February 23, 2016 - ASM Endorses Letter Requesting Additional Funding for Zika
The ASM signed onto a letter sent to Congress supporting the White House request for supplemental funds to prepare for and respond to Zika.

February 12, 2016 - ASM Letter to Congress Regarding Zika Virus
The ASM sent a letter to Congress supporting the President's supplemental budget request of $1.8 billion to prepare and respond to the Zika virus outbreak.

 

 

 

Centers for Disease Control and Prevention - FY 2017

The ASM submitted funding recommendations to Congress regarding funding for the Centers for Disease Control and Prevention for fiscal year 2017.

July 27, 2016 - ASM Asks VA for Clarification on Proposed Advance Practice Registered Nurse Duty Changes

ASM comments focus on Advance Practice Nurses ability to perform laboratory testing

National Institutes of Health - FY 2017

The ASM submitted funding recommendations to Congress about the National Institutes of Health for FY 2017.

ASM Urges Congressional Action on Emergency Zika Funding

The ASM sent a letter to Majority Leader McConnell and Minority Leader Reid, Speaker Ryan and Minority Leader Pelosi urging action on Zika funding legislation.

February 19, 2016 - ASM Letter Supports Increased AFRI Funding

The ASM sent a letter to Congress supporting a funding level of $700 million in the FY 2017 budget for the U.S. Department of Agriculture’s Agriculture and Food Research Initiative (AFRI).

May 18, 2016 - ASM Supports $1.9 Billion Emergency Funding to Combat Zika

The ASM sent a letter to Congress supporting the full $1.9 emergency funding request to combat Zika.

February 12, 2016 - ASM Letter to Congress Regarding Zika Virus

The ASM sent a letter to Congress supporting the President's supplemental budget request of $1.8 billion to prepare and respond to the Zika virus outbreak.

May 11, 2016 – ASM Comments on Department of Labor Employee Exemptions Definitions Impact on Research

The ASM sent a letter to Howard A. Shelanski, Ph.D., Administrator, Office of Information and Regulatory Affairs, Office of Management and Budget regarding the impact of the Department of Labor’s “Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales and Computer Employees” on research.

2016 Statements and Testimony

Statements and Testimony from 2016

April 8, 2016 - ASM Letter on Zika and Emerging Infectious Disease Funding

The ASM sent a letter to Congress regarding emergency funding for the Zika outbreak.  The ASM supports providing new funding to fight public health emergencies.

2016 Statements and Testimony (2)

Statements and Testimony from 2016

TPL_asm2013_SEARCH

137